St. Louis startup developing cancer-fighting drug raises $21M
April 06, 2022 at 15:12 PM EDT
The St. Louis biotechnology startup plans to use its new funding to advance clinical trials of its lead drug candidate.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|